Ortho Evra (contraceptive patch)

Please read: Important 2013 cancer research update from Dr. Michael Camilleri

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Why it's done

By Mayo Clinic staff

Ortho Evra is used to prevent pregnancy. Ortho Evra has some advantages over other types of birth control:

  • It eliminates the need to interrupt sex for contraception or seek partner compliance
  • It doesn't require daily attention
  • It provides a steady dose of hormones
  • It can be removed at any time, allowing for a quick return to fertility

Ortho Evra isn't appropriate for everyone, however. Your health care provider may recommend against using Ortho Evra if you:

  • Are age 35 or older and smoke
  • Have chest pain or a history of heart attack, stroke or severe high blood pressure
  • Have a history of blood clots
  • Have a history of breast, uterine or liver cancer
  • Weigh more than 198 pounds (90 kilograms)
  • Have liver disease, migraines with aura, or diabetes-related complications of the kidneys, eyes, nerves or blood vessels
  • Have unexplained vaginal bleeding
  • Developed yellowing of the whites of the eyes or of the skin (jaundice) during pregnancy or previous use of hormonal contraceptives
  • Are about to be immobilized for a prolonged period due to major surgery
  • Are sensitive to any components of Ortho Evra

In addition, tell your health care provider if you:

  • Are breast-feeding or recently gave birth, had a miscarriage or an abortion
  • Have breast lumps, fibrocystic disease, an abnormal mammogram or a family history of breast cancer
  • Have epilepsy, diabetes, or gallbladder, liver, heart or kidney disease
  • Have high cholesterol or triglycerides
  • Have irregular periods
  • Have depression
  • Have skin conditions, such as psoriasis or eczema
References
  1. Birth control methods fact sheet. U.S. Department of Health and Human Services. http://www.womenshealth.gov/publications/our-publications/fact-sheet/birth-control-methods.cfm. Accessed Nov. 9, 2012.
  2. Ortho Evra (prescribing information). Raritan, N.J.: Ortho-McNeil-Janssen Pharmaceuticals Inc.; 2012. http://www.orthoevra.com/fullprescribeinfo.html. Accessed Nov. 14, 2012.
  3. Zieman M. Overview of contraception. http://www.uptodate.com/home/. Accessed Nov. 9, 2012.
  4. Hatcher RA, et al. Contraceptive Technology. 20th ed. New York, N.Y.: Ardent Media; 2011:343.
  5. Burkman RT. Transdermal contraceptive patch. http://www.uptodate.com/index. Accessed Nov. 14, 2012.
  6. Dore DD, et al. Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users. Contraception. 2010;81:408.
MY01006 Jan. 10, 2013

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger